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Abstract
Background: When breastfeeding is not possible, infants are fed formulas in which lipids are usually of plant origin.
However, the use of dairy fat in combination with plant oils enables a lipid profile in formula closer to breast milk
in terms of fatty acid composition, triglyceride structure and cholesterol content. The objectives of this study were
to investigate the impact on growth and gastrointestinal tolerance of a formula containing a mix of dairy lipids and
plant oils in healthy infants.
Methods: This study was a monocentric, double-blind, controlled, randomized trial. Healthy term infants aged less than
3 weeks whose mothers did not breastfeed were randomly allocated to formula containing either: a mix of plant oils and
dairy fat (D), only plant oils (P) or plant oils supplemented with long-chain polyunsaturated fatty acids (PDHA). Breastfed
infants were included in a reference group (BF). Anthropometric parameters and body composition were measured after
2 and 4 months. Gastrointestinal tolerance was evaluated during 2 day-periods after 1 and 3 months thanks to descriptive
parameters reported by parents. Nonrandomized BF infants were not included in the statistical analysis.
Results: Eighty eight formula-fed and 29 BF infants were enrolled. Gains of weight, recumbent length, cranial circumference
and fat mass were similar between the 3 formula-fed groups at 2 and 4 months and close to those of BF. Z-scores for
weight, recumbent length and cranial circumference in all groups were within normal ranges for growth standards. No
significant differences were noted among the 3 formula groups in gastrointestinal parameters (stool frequency/consistency/
color), occurrence of gastrointestinal symptoms (abdominal pain, flatulence, regurgitation) or infant’s behavior.
Conclusions: A formula containing a mix of dairy lipids and plant oils enables a normal growth in healthy newborns. This
formula is well tolerated and does not lead to abnormal gastrointestinal symptoms. Consequently, reintroduction of dairy
lipids could represent an interesting strategy to improve lipid quality in infant formulas.
Trial registration: ClinicalTrials.gov Identifier NCT01611649, retrospectively registered on May 25, 2012.
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Background
Breastfeeding is considered by the World Health
Organization (WHO) as the best choice for infant feed-
ing. Human milk composition is used as a guideline for
establishing minimum and maximum levels of nutrients
in formulas in order to meet infant’s needs. Lipids are
major components in human milk, providing 45–55% of
total energy intake. They fulfill various metabolic and
physiological functions critical for the development,
growth and health of the newborn [1]. Human milk
contains a wide variety of lipid species, present as milk
fat globules with a core containing triacylglycerols (more
than 98% of total lipids), surrounded by a milk fat globule
membrane with complex lipids (phospholipids and sphin-
golipids), esterified cholesterol, proteins and glycoproteins.
Human milk provides alpha-linolenic (ALA) and linoleic
acids (LA) which are essential fatty acids (EFA). They can
be endogenously converted by the newborn into long-
chain derivatives of Omega 3 and Omega 6 families, such
as docosahexaenoic acid (DHA) and arachidonic acid
(ARA), respectively [2]. However, this conversion is con-
sidered as low in humans. Human milk also contains
preformed DHA and ARA, at levels strongly influenced
by the mother’s diet. These fatty acids (FA) constitute the
main components of the brain and they have an important
impact on neuronal and visual functions [3].
Fat sources used in most infant formulas currently mar-
keted are a mixture of plant oils. Indeed, since the middle
of twentieth century, infant formulas have been enriched
in EFA-rich plant oils and bovine milk fat has been pro-
gressively removed. Infant formulas can also be optionally
supplemented with fish/algae/single cell oils providing
preformed DHA and ARA. However, lipids of plant oils
are not comparable to lipids of human milk in terms of
FA diversity, triacylglycerol structure, fat globule compos-
ition, complex lipids and cholesterol contents. Conse-
quently, infant formulas provide milk-specific FA and
cholesterol only when dairy lipids are used as a fat source
in combination with plant oils [1]. Also, the nature of fat
sources used in formulas strongly influences their FA
composition. In particular, short and medium chain FA,
lauric acid, myristic acid and palmitic acid contents can
vary considerably according to the use of palm oil, coco
oil or dairy lipids [1]. Moreover, plant oils do not possess
the specific triglyceride structure found in breast milk or
cow’s milk with palmitic acid in sn2 position. The trigly-
ceride structure is of particular importance because long-
chain saturated FA in the sn2 position are more efficiently
digested and absorbed [4].
Dairy lipids specifically contain about 10% of myristic
acid and 10% of short and medium chain FA (C4-C10)
while plant oils provide much less of these FA. Short chain
FA represent a rapid source of energy for the infant,
because they enter directly the portal vein and are known
to be completely absorbed and oxidized. Myristic and
short/medium chain FA could also increase bioavailability
and conversion of n-3 PUFA [5]. Also, it was shown in
adults that a moderate intake of dairy lipids and rapeseed
oil improved DHA levels in erythrocytes and blood fluidity
[6, 7]. Furthermore, recent studies in omega 3-deficient
rodents have demonstrated that for a similar ALA con-
tent, a blend of dairy lipids and rapeseed oil induced a
higher level of brain DHA than a blend of plant oils even
if supplemented with preformed DHA [8, 9].
Consequently, dairy lipids could represent an interesting
strategy to improve lipid composition of infant formula in
order to better mimic human milk composition and struc-
ture and to optimize growth and health of the infant. In
this study, we evaluated the impact on growth as well as
the tolerance to a formula containing a blend of dairy
lipids and plant oils during the first 4 months of life.
Methods
Study design
This monocentric, double-blind, controlled, randomized
trial was conducted in 2012–2013 in the Department of
Neonatology of the Fondazione IRCCS Cà Granda Ospedale
Maggiore Policlinico, Milano, Italy (NCT01611649). The
study was approved by the local Ethical Committee and
conducted in accordance with Good Clinical Practice and
the principles and rules of the Declaration of Helsinki. Par-
ents or legal caregivers provided written informed consent
prior to enrollment of their infants in the study. The study
protocol has been previously published [10].
Population
Healthy full-term infants born in the Department of
Neonatology were screened for participation in the
study. When breastfeeding was not possible (contraindi-
cation or mothers not intended to breastfeed), infants
were randomly allocated to be fed for 4 months with a
formula containing either: a mix of plant oils and dairy
fat (D), only plant oils (P) or plant oils supplemented
with ARA and DHA (PDHA). Infants whose mothers
intended to exclusively breastfeed from birth through at
least 4 months were enrolled in a nonrandomized refer-
ence group (BF). Inclusion criteria were: gestational age
37 to 42 weeks, birth weight > 2500 g, healthy newborns
from normal pregnancy, aged up to 3 weeks when enter-
ing the study, no breastfeeding (for the formula-fed
groups) or exclusive breastfeeding (for the reference
group). Exclusion criteria were: positive family history of
allergy to milk proteins, known congenital or postnatal
diseases which could interfere with the study and new-
borns whose parents had planned to move within
6 months after birth.
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Study formulas
Study formulas were formulated into powders and were
reconstituted at 13.3%. They were manufactured and pro-
vided by Milumel®, Lactalis, Craon, France. The 3 tested
formulas were packaged in blinded containers labeled only
with study details and number of randomization; they
were indistinguishable in appearance and texture. The
randomization schedule was computer-generated and
stratified on sex. Sequentially numbered tins of infant for-
mula were prepared according to this schedule. Once the
newborn was enrolled, he/she was allocated to the next
available randomization number which corresponded to
the allocation to one of the 3 study formulas. Both the
investigators and the infants’ parents were blind to the
group allocation. Compositions of the 3 study formulas
were in compliance with the European Directive 2006/
141/EC on infant formulas and are detailed in Table 1
(manufacturer data). The 3 formulas had similar energy
and macronutrient contents but they differed by the
nature of their lipid sources. Formula D contained a mix-
ture of dairy lipids and plant oils; formula P contained
only plant oils and formula PDHA contained plant oils
supplemented with ARA and DHA. Study formulas were
consumed straightaway after randomization and were pro-
vided for the 4 subsequent months.
Objectives and outcomes
The main objective of this study was to investigate the
effect of formula D on the erythrocyte membrane Omega
3 fatty acid content as compared to formulas P and PDHA
[10]. The secondary objective was to evaluate the safety of
infants consuming formula D in comparison to infants
consuming formula P and PDHA and to breastfed infants.
Therefore, the impact of formulas on growth, body com-
position and gastrointestinal tolerance was assessed and
only these results are reported in this article.
Evaluation of growth, body composition and
gastrointestinal tolerance
Baseline data (sex, gestational age at birth, mode of deliv-
ery and anthropometric measurements) were recorded at
enrollment. Growth and body composition were evaluated
at enrollment and after 2 and 4 months of consumption
of the allocated formula (or breastfeeding) during follow-
up visits. The infants’ anthropometric measurements
(body weight, length, head circumference) were obtained
using standardized techniques. Subject mass was mea-
sured on an electronic scale accurate to the nearest 0.1 g.
Recumbent length was measured on a Harpenden stadi-
ometer to the nearest 1 mm. The head circumference was
measured using a non-stretch measuring tape to the near-
est 1 mm. Z-scores for weight, length and head circumfer-
ence were then calculated with WHO Anthro for personal
computers, version 3.2.2, 2011 (http://www.who.int/child-
growth/software/en/). Body composition was assessed
using an air displacement plethysmography system (PEA
POD Infant Body Composition System, COSMED- USA).
A detailed description of the PEA POD’s physical design,
operating principles, validation and measurement proce-
dures is provided elsewhere [11, 12]. The PEA POD as-
sesses fat mass and fat free mass by direct measurements
of body mass and volume and the application of classic
densitometric principles.
Gastrointestinal (GI) tolerability was evaluated thanks to
diaries filled by parents for 2-day periods before a phone
call planned after 1 and 3 months of consumption of the
allocated formula (or breastfeeding). Specifically, the follow-
ing indicators of GI tolerability were collected through
multiple-choice questions: volume of formula intake, daily
frequency of stool passage, stool consistency and color,
episodes and type of regurgitations (no regurgitation/regur-
gitations of small amounts/regurgitations of large amounts/
vomits), episodes of flatulence and abdominal pain (defined
as intermittent attacks of abdominal pain when the baby
screams and draws up his/her legs but is well between
episodes). Sleeping disturbances and general behavior were
Table 1 Composition of study formulas
Formula D Formula P Formula PDHA
100 mla 100 mla 100 mla
Energy kJ 275 275 275
kcal 66 66 66
Protein g 1.3 1.3 1.3
Carbohydrates g 8.1 8.1 8.1
Lactose
g 6.8 6.8 6.8
Fat g 3.1 3.1 3.1
LA
mg 439 549 549
%
TFA
14.2 17.7 17.7
ALA
mg 73 55 55
%
TFA
2.3 1.8 1.8
Ratio LA/ALA 6 10 10
ARA
mg 12.4
%
TFA
0.4
DHA
mg 6.2
%
TFA
0.2
Ratio ARA/DHA 2
aReconstituted 13.3%
Composition of tested formulas according to manufacturer data. Formula D
contained a mixture of dairy lipids and plant oils; formula P contained only
plant oils and formula PDHA contained plant oils supplemented with ARA
and DHA. LA linoleic acid, ALA alpha-linolenic acid, ARA arachidonic acid,
DHA docosahexaenoic acid, TFA total fatty acids
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also described. Adverse events were recorded throughout
the study period.
Sample size
Calculation of sample size for this study has been previ-
ously detailed [10].
Statistical analyses
Statistical analyses were performed using SAS software
(SAS Institute Inc., Cary NC, USA) by Soladis, Lyon,
France. All statistical analyses were performed on an
intention to treat basis. Continuous variables were
expressed as mean and standard deviation. Differences
among groups for growth parameters were analyzed with
an analysis of variance with 3 fixed factors (formula, sex,
time). Differences among groups for GI parameters were
analyzed with ordinal or binary logistic model on for-
mula and time effects with age as covariate. A p-value <
0.05 was considered significant. As the breastfed infants
were not randomized, no statistical analysis was per-
formed to compare the breastfed group with any of the
formula-fed groups.
Results
Study population
A total of 117 healthy newborns were enrolled. Of these,
88 were randomized to the formula-fed groups and 29
were enrolled in the breastfed reference group (Fig. 1). A
total of 18 (20%) infants from the formula groups and 10
(34%) in the breastfed group withdrew before the end of
the study (Fig. 1). Rates of discontinuation were similar
in the 3 formula groups (23% in formula D and PDHA;
14% in formula P). GI symptoms (ie. regurgitations,
reflux, constipation, abdominal pain and flatulence) were
the most common reason for study discontinuation in
the 3 formula groups: 57% in group D, 75% in group P
and 43% in group PDHA. Among the breastfed group, 8
babies were lost to follow-up and breastfeeding was
stopped before the next visit for 2 babies.
Baseline characteristics in each group are presented in
Table 2. Ethnicity was not recorded in this study.
Proportion of boys was similar in the 3 formula groups
(53–57%; p = 0.851) and was of 38% in the breastfed
reference group (Table 2). A high proportion of caesar-
ean births (43–64%) was observed in all groups without
any difference among the 3 formula groups (p = 0.185).
Gestational age was around 38 weeks in the 3 for-
mula groups (p = 0.970) and around 39 weeks in the
breastfed group. On average, infants were enrolled in
the study at 5–10 days of life (Table 2). Age at inclusion
was significantly different in the 3 formula groups
(p = 0.016) with a lower age in group P than in group
PDHA (4.9 ± 4.5 vs. 9.6 ± 7.9 days; p = 0.012). Weight,
recumbent length, head circumference and body compos-
ition were similar in the 3 formula groups at baseline (all
p > 0.05) (Table 2).
Mean daily volume of formula consumed was evalu-
ated during a 2 day-period at 1 month and 3 months.
Most of formula-fed infants consumed more than
600 ml daily at 1 month (around 95% of infants) and
more than 700 ml daily at 3 months (around 82%). No
significant differences in formula intake were observed
among the 3 formula groups at 1 month (p = 0.980) or
at 3 months (p = 0.177).
Fig. 1 Flow of study subjects. Formula D contained a mixture of dairy lipids and plant oils; formula P contained only plant oils and formula PDHA
contained plant oils supplemented with ARA and DHA. GI (gastrointestinal) symptoms included regurgitations, reflux, constipation, abdominal
pain and flatulence
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Growth
Mean weight gains in formula groups were 1.9–2.2 kg at
2 months (33–36 g/day) and 3.4–3.8 kg at 4 months
(27–31 g/day). In breastfed infants, weight gain was
2.1 kg at 2 months (33 g/day) and 3.3 kg at 4 months
(28 g/day). No differences of daily weight gains were ob-
served among the 3 formula groups (p = 0.211) (Table 3).
Mean daily gains in length were not significantly differ-
ent among the 3 groups despite a tendency (p = 0.055).
In particular, length gain tended to be lower with for-
mula P than with formula D and PDHA (Table 3). Over-
all, gains in length were significantly lower in girls than
in boys (p = 0.05). Finally, daily gains in head circumfer-
ence were similar in the 3 formula groups (p = 0.082).
Compared with WHO growth standards, infants in all
groups grew normally throughout the study. Mean values
for all growth measures through 4 months of age were
within 1 SD of the WHO median values (Fig. 2).
Body composition was similar in the 3 formula-fed
groups after 2 and 4 months (Fig. 3). Fat mass significantly
increased over time (p < 0.001) and was significantly
higher in girls than in boys (p = 0.008) without any differ-
ence among the 3 formula-fed groups (p = 0.489) (Fig. 3).
GI tolerability
Daily stool frequency was comprised between 1 and 3
stools per day for the majority of formula-fed infants at
1 month (88–96%) and 3 months of age (87–96%) (Fig. 4).
At 1 month, one infant in each formula group had a stool
frequency of 4–6 stools/day and 2 infants in the formula
D group had less than 1 stool/day (Fig. 4). At 3 months,
no formula-fed infant had 4–6 stools/day but some had
less than 1 stool/day (3 in formula D, 1 in formula P and 2
in PDHA). No significant difference was observed among
the 3 formula groups for daily stool frequency (p = 0.335).
In the breastfed group, daily stool frequency distribution
was more equally spread among classes, with 42% and
75% of infants with 1–3 stools per day at 1 and 3 months,
respectively; 27% and 10% with 4–6 stools/day; 15% and
10% with 7–10 stools/day and 15% and 5% with less than
Table 2 Infants’ characteristics at enrollment
Formula D Formula P Formula PDHA Breastfed p-value
n = 30 n = 28 n = 30 n = 29
Sex, no. (%) Girls 13 (43.3) 11 (39.3) 14 (46.7) 18 (62.1) 0.851
Boys 17 (56.7) 17 (60.7) 16 (53.3) 11 (37.9)
Delivery mode, no. (%) Natural 11 (36.7) 10 (35.7) 17 (56.7) 14 (48.3) 0.185
Caesarean 19 (63.3) 18 (64.3) 13 (43.3) 15 (51.7)
Gestational age, weeks, mean (SD) 38.4 (1.2) 38.4 (1.1) 38.3 (1.0) 39.0 (1.0) 0.970
Age at enrollment, days, mean (SD) 6.8 (5.6) 4.9 (4.5) X 9.6 (7.9) 8.8 (6.6) 0.016*
Weight, g, mean (SD) 3144.2 (448.6) 2942.9 (386.6) 3156.4 (431.8) 3308.7 (533.9) 0.107
Recumbent length, cm, mean (SD) 49.1 (2.2) 48.9 (2.2) 49.7 (1.9) 50.1 (1.8) 0.351
Head circumference, cm, mean (SD) 34.4 (1.2) 34.3 (1.4) 34.7 (1.4) 35.3 (2.0) 0.476
Fat mass FM, mean (SD) % BW 10.3 (2.9) 10.8 (3.4) 9.8 (3.5) 11.6 (5.4) 0.487
Fat-free mass FFM, mean (SD) % BW 89.7 (2.9) 89.2 (3.4) 90.2 (3.5) 88.4 (13.8) 0.487
Formula D contained a mixture of dairy lipids and plant oils; formula P contained only plant oils and formula PDHA contained plant oils supplemented with ARA
and DHA. FM fat mass, FFM fat-free mass, BW body weight. Comparison of the 3 formula groups by ANOVA 1 fixed factor (Formula); * p < 0.05; X p < 0.05
vs. PDHA
Table 3 Growth rates between baseline and 2 or 4 months of age
Formula D Formula P Formula PDHA Breastfed p-value
n 2 mo 23 25 24 22
4 mo 23 24 23 19
Weight gain, g/day, mean (SD) 2 mo 34.0 (7.1) 33.0 (9.7) 36.2 (6.8) 32.8 (7.7) 0.211
4 mo 30.0 (5.1) 27.3 (5.0) 31.3 (5.3) 27.6 (6.8)
Length gain, mm/day, mean (SD) 2 mo 1.34 (0.33) 1.22 (0.38) 1.35 (0.33) 1.38 (0.35) 0.055
4 mo 1.16 (0.18) 1.05 (0.17) 1.17 (0.15) 1.06 (0.17)
Head circumference gain, mm/day, mean (SD) 2 mo 0.78 (0.13) 0.71 (0.20) 0.78 (0.19) 0.65 (0.19) 0.082
4 mo 0.62 (0.08) 0.57 (0.09) 0.64 (0.08) 0.54 (0.15)
Formula D contained a mixture of dairy lipids and plant oils; formula P contained only plant oils and formula PDHA contained plant oils supplemented with ARA
and DHA. Comparison of the 3 formula group by ANOVA 3 fixed factors (Sex, Time, Formula and all interactions)
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1 stool/day (Fig. 4). Stool consistency was mainly creamy
in formula-fed infants at 1 month (71–81%) and 3 months
(76–91%), sometimes solid but rarely liquid (Fig. 4). No
significant difference was observed among the 3 formula
groups for stool consistency (p = 0.486). Breastfed infants
also had mainly creamy stools (75–77%) but they were
more likely to have liquid but not solid ones (Fig. 4). Stool
color was mainly green in formula D-fed infants at 1 month
(48%) while it was mainly ocher/bronze in groups P and
PDHA (42 and 57% respectively). At 3 months, stools were
mainly ocher/bronze for the 3 formula groups (Fig. 4).
Stools of breastfed infants were mainly gold yellow or
ocher/bronze but never green (Fig. 4).
No significant difference was reported among the 3 for-
mula in caregivers’ reports of abdominal pain (p = 0.823)
which was more frequent at 1 month (27–44% of infants)
than at 3 month (9–13% of infants; p = 0.02). In the breast-
fed group, abdominal pain was reported in 54 and 80% of
infants at 1 and 3 months, respectively (Table 4). Reports of
flatulence were similar in the 3 groups (p = 0.125) and they
were more frequent at 1 month (68–85% of infants) than at
3 months (57–68%; p = 0.001). In the breastfed group,
flatulence affected 65 and 60% of infants, respectively
(Table 4). Sleeping disturbances were observed in 8–25% of
formula-fed infants at 1 month and 4–24% of infants at
3 months, without statistical differences among groups
(p = 0.276). General behavior was described similarly in
the 3 formula groups (p = 0.651) (Table 4).
At 1 month, regurgitations of small amounts of formula
or breast milk after the meal were frequent in all groups
(around 50% of infants) without any difference among
groups (p = 0.742). Between 1 and 3 months, frequency of
regurgitations decreased significantly (p = 0.028) without
any difference among groups (Fig. 5). No vomit was de-
scribed and regurgitations of big amounts were reported
only in 1 formula D-fed and 2 formula P-fed infants at
1 month and in 1 breastfed infant at 3 months (Fig. 5).
Discussion
This study demonstrated that 4-month consumption of a
formula containing dairy lipids was associated with nor-
mal growth in healthy term infants and was well tolerated.
Fig. 2 Mean growth measurements of infants relative to WHO growth
standards. Formula D contained a mixture of dairy lipids and plant oils;
formula P contained only plant oils and formula PDHA contained plant
oils supplemented with ARA and DHA. WHO: World Health Organization
Fig. 3 Body composition expressed in percentage of body weight at baseline, 2 months and 4 months in formula-fed and breastfed infants. Formula
D contained a mixture of dairy lipids and plant oils; formula P contained only plant oils and formula PDHA contained plant oils supplemented with
ARA and DHA. BW: body weight. Comparison of the 3 formula group by ANOVA 3 fixed factors (Sex, Time, Formula and all interactions)
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There were no statistically significant differences in
weight, length, or head circumference growth rates among
groups fed with formula containing either a mix of dairy
and plant lipids, or a blend of plant oils (with or without
ARA and DHA). Long Chain PUFA addition had no effect
on growth. In this study, growth rates of formula-fed were
close to those of breastfed babies. Furthermore, weight,
length and head circumference measurements during the
4 first months of life in all groups were similar to the
WHO growth standards.
One limitation of this study is that sample size was not
initially calculated for the specific outcomes presented
here, in particular weight gain. According to the guidance
provided by the American Academy of Pediatrics [13], the
number of subjects of a specified sex needed in each
group to detect a 3 g/day difference in weight gain over a
3.5 month-period with a power of 0.8 in a one- tailed test
is 28. Consequently, this study might be underpowered to
detect a statistical difference in weight gain. Body compos-
ition was also similar in the 3 formula groups. It has been
previously described that formula-fed had different body
composition compared to breastfed babies, with higher
fat-free mass (in grams) at 4 months and higher fat-free
mass changes between enrollment and 4 months [14].
However, in this previous study, fat mass and fat-free mass
at 4 months (both expressed in % of body weight) were
similar between breastfed and formula-fed babies [14]. In
our study, fat mass and fat-free mass values in 4 month-
Fig. 4 Infants’ stool frequency, consistency and color at 1 and 3 months of age. Formula D contained a mixture of dairy lipids and plant oils; formula P
contained only plant oils and formula PDHA contained plant oils supplemented with ARA and DHA. BF: breastfed. Comparison of the 3 formula group
by ordinal logistic model on formula and time effects with age as covariate
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old formula-fed infants were close to those described by
Gianni et al., 2014 (around 27% and 73% of body weight,
respectively). Fat-free mass change after 4 months was
also lower in breastfed infants (+ 62%) than in formula-fed
babies (+ 74–83%). These results suggest that formula-fed
infants show different body composition development
during the first 4 months of life compared to breastfed
babies. However, the nature of fat used in the tested for-
mulas did not significantly affect body composition.
No significant differences were noted among the 3 for-
mula groups in gastrointestinal parameters (stool frequency,
consistency or color), occurrence of gastrointestinal symp-
toms (abdominal pain, flatulence, regurgitation or vomiting)
or infant’s behavior. Stool frequency tended to be higher in
breastfed than formula-fed babies (with 42% and 20% of
breastfed infants at 1 month at 3 months, respectively, hav-
ing more than 4 stools/day versus 4 and 0% of formula-fed
ones). This result is in agreement with previous data show-
ing that breastfed infants pass stools almost 50% more often
than formula-fed ones [15]. Moreover, solid stools were
observed more often in formula-fed than in breastfed babies
(19–24% at 1 month and 9–24% at 3 months in formula-fed
versus 4 and 0% in breastfed). It has been previously
reported that hard stools are associated with formula feeding
and are related to the presence of excreted fatty acid soaps
and calcium [16]. Indeed, palmitic acid from plant oils is
differentially arranged in the triglyceride (mainly in sn1 and
sn3 position, only 5–20% in sn2 position also called beta-
palmitate) from palmitic acid from breast milk (60% of beta-
palmitate). Palmitic acid from plant oils is poorly absorbed
and can react with calcium to form insoluble soaps leading
to decreased fat and calcium absorption and increased stool
hardness [17]. In dairy lipids, around 45% of palmitic acid is
esterified in sn2 position [18]. In infant formula, this results
in a lower proportion of beta-palmitate in formulas contain-
ing only vegetable oils compared with formulas containing
dairy lipids or structured lipids [19]. In our study, the for-
mula containing dairy lipids contained more beta-palmitate
Table 4 Occurrence of abdominal pain, flatulence and sleeping disturbances and description of behavior in infants at 1 and 3 months
of age
1 month 3 months
Formula D
n = 25
Formula P
n = 26
Formula PDHA
n = 28
Breastfed
n = 26
Formula D
n = 23
Formula P
n = 25
Formula PDHA
n = 23
Breastfed
n = 20
No. % No. % No. % No. % No. % No. % No. % No. %
Abdominal pain 11 44 7 27 11 39 14 54 2 9 3 12 3 13 16 80
Flatulence 17 68 22 85 21 75 17 65 13 57 17 68 13 57 12 60
Sleeping disturbances 2 8 4 15 7 25 10 38 1 4 6 24 1 4 4 20
Behavior Quiet 17 68 15 58 18 64 20 77 15 65 12 48 11 48 7 35
Active 8 32 9 35 7 25 5 19 8 35 13 52 11 48 13 65
Disturbed/restless 0 0 2 8 3 11 1 4 0 0 0 0 1 4 0 0
Formula D contained a mixture of dairy lipids and plant oils; formula P contained only plant oils and formula PDHA contained plant oils supplemented with ARA
and DHA. Comparison of the 3 formula group by binary logistic model on formula and time effects with age as covariate
Fig. 5 Description of regurgitations and vomits in infants at 1 (left) and 3 months (right). Formula D contained a mixture of dairy lipids and plant
oils; formula P contained only plant oils and formula PDHA contained plant oils supplemented with ARA and DHA. Comparison of the 3 formula
group by binary logistic model on formula and time effects with age as covariate
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than formulas with blends of plant oils. However, no differ-
ence was observed among these formula on the occurrence
of solid stools. This could be due to methodological consid-
erations with a low number of babies in each group and the
inaccuracy of stool consistency report (only 2 time points
with evaluation on the last 2 days). Further investigation
would be required especially to evaluate if the nature of fat
in formula has an impact on fat content in stools.
A high frequency of gastrointestinal symptoms was
present throughout the study, especially regurgitations
which affected around 50% of babies at 1 month and
around 30% of babies at 3 months, without any difference
among groups. However, regurgitation can be considered
as a physiological phenomenon in the first year of life and
these frequencies are in accordance with previous data
reporting that more than 50% of infants aged 0–5 months
regurgitate at least once a day [20]. Intermittent episodes
of abdominal pain were also observed in 27–44% of
formula-fed infants at 1 month and 9–13% at 3 months,
which is slightly higher than in the usual range of inci-
dence for colic [21]. However, in our study, the incidence
of colic, as defined by Wessel [22], was not evaluated.
Therefore, the tolerability and safety of a formula contain-
ing a mix of dairy and plant lipids did not appear to be
different from formulas containing blend of plant oils with
or without ARA and DHA.
Conclusions
A formula containing dairy lipid provides adequate nutri-
tion for normal growth in healthy term infants and is as
well tolerated as control formulas containing only plant
oils as lipid sources. Long Chain PUFA addition in a plant
oil-based formula has no effect on growth and formula
tolerance. Breast milk remains the food of choice but for
infants who cannot be breastfed, this study shows that a
formula containing dairy lipids having a fat profile closer
to breast milk is an appropriate alternative. Further
research is needed to investigate the impact of a dairy
lipid-containing formula on growth of low birth weight
preterm infants as well as its health benefits both in term
and preterm infants.
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